TABLE OF CONTENTS 1. INTRODUCTION 1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF EUROPE CANCER DIAGNOSTICS MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED 2. MARKET SEGMENTATION 2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS 3. MARKET OVERVIEW 3.1. DRIVERS 3.1.1. GROWTH OF AGING POPULATION AND RISING PREVALENCE OF CANCER 3.1.2. GOVERNMENT INITIATIVES FOR FUNDING AND AWARENESS ABOUT CANCER 3.1.3. KEY PLAYERS FOCUSING ON STRATEGIC DECISIONS TO GAIN MARKET SHARE 3.1.4. INCREASING PREVELANCE OF CANCER   3.2. RESTRAINTS 3.2.1. STRINGENT REULATIONS IMPOSED BY INTERNATIONAL AND LOCAL AUTHORITIES 3.2.2. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS 3.3. OPPORTUNITIES 3.3.1. NANOTECHNOLOGY: FORTHCOMING REVOLUTION IN CANCER DIAGNOSIS 3.3.2. ARTIFICIAL INTELLIGENCE AND THE IMMINENT HEALTH REVOLUTION 3.3.3. GROWING MEDICAL TOURISM IN ASIA 3.4. CHALLENGES 3.4.1. INCREASING RIVALRY AMONG THE COMPETITORS 3.4.2. POOR ACCESS TO CANCER DETECTION AND HIGH TREATMENT COCTS IN LOWER INCOME COUNTRIES 4. PREMIUM INSIGHTS 5. EXECUTIVE SUMMARY 6. EUROPE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. PLATFORM BASED 6.2.1. POLYMERASE CHAIN REACTION(PCR) 6.2.2. IN SITU HYBRIDIZATION (ISH) 6.2.3. IMMUNOHISTOCHEMISTRY(IHC) 6.2.4. NEXT GENERATION SEQUENCING (NGS) 6.2.5. DNA MICROARRAYS 6.2.6. FLOW CYTOMETRY 6.3. INSTRUMENT BASED 6.3.1. IMAGING 6.3.1.1. MAGENTIC RESONANCE IMAGING (MRI) 6.3.1.2. CT(COMPUTED TOMOGRAPHY) 6.3.1.3. POSITRON EMISSION TOMOGRAPHY- COMPUTED TOMOGRAPHY (PET-CT) 6.3.1.4. MAMMOGRAPHY 6.3.1.5. ULTRASOUND 6.3.2. BIOPSY 7. EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 7.1. OVERVIEW 7.2. LUNG CANCER 7.3. BREAST CANCER 7.4. COLORECTAL CANCER 7.5. MELANOMA 7.6. OTHERS 8. EUROPE CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY 8.1. OVERVIEW 8.2. EUROPE CANCER DIAGNOSTICS MARKET 8.2.1. GERMANY CANCER DIAGNOSTICS MARKET 8.2.2. FRANCE CANCER DIAGNOSTICS MARKET 8.2.3. U.K. CANCER DIAGNOSTICS MARKET 8.2.4. ITALY CANCER DIAGNOSTICS MARKET 8.2.5. SPAIN CANCER DIAGNOSTICS MARKET 8.2.6. RUSSIA CANCER DIAGNOSTICS MARKET 8.2.7. TURKEY CANCER DIAGNOSTICS MARKET 8.2.8. BELGIUM CANCER DIAGNOSTICS MARKET 8.2.9. NETHERLANDS CANCER DIAGNOSTICS MARKET 8.2.10. SWITZERLAND CANCER DIAGNOSTICS MARKET 8.2.11. REST OF EUROPE CANCER DIAGNOSTICS MARKET 9. EUROPE CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 9.1. COMPANY SHARE ANALYSIS: EUROPE CANCER DIAGNOSTICS IMAGING MARKET 9.2. COMPANY SHARE ANALYSIS: EUROPE CANCER DIAGNOSTICS PLATFORM BASED MARKET 10. COMPANY PROFILES 10.1. C. R. BARD, INC. 10.1.1. COMPANY OVERVIEW 10.1.2. REVENUE ANALYSIS 10.1.3. PRODUCT PORTFOLIO 10.1.4. RECENT DEVELOPMENTS 10.2. ILLUMINA, INC. 10.2.1. COMPANY OVERVIEW 10.2.2. REVENUE ANALYSIS 10.2.3. RECENT DEVELOPMENTS 10.2.4. PRODUCT PORTFOLIO 10.3. QIAGEN 10.3.1. COMPANY OVERVIEW 10.3.2. REVENUE ANALYSIS 10.3.3. RECENT DEVELOPMENTS 10.3.4. PRODUCT PORTFOLIO 10.4. ABBOTT 10.4.1. COMPANY OVERVIEW 10.4.2. REVENUE ANALYSIS 10.4.3. RECENT DEVELOPMENTS 10.4.4. PRODUCT PORTFOLIO 10.5. SIEMENS HEALTHCARE GMBH 10.5.1. COMPANY OVERVIEW 10.5.2. REVENUE ANALYSIS 10.5.3. RECENT DEVELOPMENTS 10.5.4. PRODUCT PORTFOLIO 10.6. AGILENT TECHNOLOGIES 10.6.1. COMPANY OVERVIEW 10.6.2. REVENUE ANALYSIS 10.6.3. PRODUCT PORTFOLIO 10.6.4. RECENT DEVELOPMENTS 10.7. THERMO FISHER SCIENTIFIC INC. 10.7.1. COMPANY OVERVIEW 10.7.2. REVENUE ANALYSIS 10.7.3. PRODUCT PORTFOLIO 10.7.4. RECENT DEVELOPMENTS 10.8. BECTON, DICKINSON AND COMPANY 10.8.1. COMPANY OVERVIEW 10.8.2. REVENUE ANALYSIS 10.8.3. PRODUCT PORTFOLIO 10.8.4. RECENT DEVELOPMENTS 10.9. GE HEALTHCARE 10.9.1. COMPANY OVERVIEW 10.9.2. REVENUE ANALYSIS 10.9.3. PRODUCT PORTFOLIO 10.9.4. RECENT DEVELOPMENTS 10.10. F. HOFFMANN-LA ROCHE LTD 10.10.1. COMPANY OVERVIEW 10.10.2. REVENUE ANALYSIS 10.10.3. PRODUCT PORTFOLIO 10.10.4. RECENT DEVELOPMENTS 10.11. HOLOGIC INC. 10.11.1. COMPANY OVERVIEW 10.11.2. REVENUE ANALYSIS 10.11.3. RECENT DEVELOPMENTS 10.11.4. PRODUCT PORTFOLIO 10.12. KONINKLIJHE PHILIPS N.V. 10.12.1. COMPANY OVERVIEW 10.12.2. REVENUE ANALYSIS 10.12.3. PRODUCT PORTFOLIO 10.12.4. RECENT DEVELOPMENTS 11. RELATED REPORTS

TABLE LIST TABLE 1 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024(USD MILLION) TABLE 2 EUROPE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 3 EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 4 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 5 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 6 EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 7 GERMANY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 8 GERMANY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 9 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 10 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 11 GERMANY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 12 FRANCE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 13 FRANCE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 14 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 15 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 16 FRANCE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 17 U.K.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 18 U.K. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 19 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 20 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 21 U.K. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 22 ITALY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 23 ITALY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 24 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 25 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 26 ITALY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 27 SPAIN CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 28 SPAIN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 29 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 30 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 31 SPAIN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 32 RUSSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 33 RUSSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 34 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 35 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 36 RUSSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 37 TURKEY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 38 TURKEY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 39 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 40 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 41 TURKEY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 42 BELGIUM CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 43 BELGIUM PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 44 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 45 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 46 BELGIUM CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 47 NETHERLANDSCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 48 NETHERLANDS PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 49 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 50 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 51 NETHERLANDS CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 52 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 53 SWITZERLAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 54 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 55 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 56 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 57 REST OF EUROPECANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 58 REST OF EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 59 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 60 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 61 REST OF EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) FIGURES LIST FIGURE 1 EUROPEAN UNION POPULATION AGES 65 AND ABOVE (% OF TOTAL) FIGURE 2 EUROPE CANCER DIAGNOSTICS MARKET SNAPSHOT (2017) FIGURE 3 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016) FIGURE 4 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2017) FIGURE 5 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024) FIGURE 6 EUROPE CANCER DIAGNOSTICS MARKET BY TECHNOLOGY (2017 & 2024)  

• Siemens Healthcare • Hologic, Inc, • Becton, • Dickinson and Company. • Thermo Fisher Scientific, Inc. • Illumina, Inc. • Roche Diagnostics, • Abbott Laboratories, Inc., • QIAGEN.